Publication | Closed Access

Complete results of the first randomized, placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension

HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseMedicineVascular PharmacologyPhysiologyPulmonary HypertensionVascular BiologyPlacebo-controlled StudyPublic HealthPharmacologyPulmonary Vascular DiseaseComplete Results